Related Experiment Video
Updated: May 5, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.8K
Quantitative and qualitative pleiotropic differences between Simvastatin single and Vytorin combination therapy in
Zohara Sternberg1, Trevor Chichelli, Daniel Sternberg
1Department of Neurology, Stroke Center, Buffalo Medical Center, Buffalo, NY, USA.
Atherosclerosis
|November 26, 2013
Summary
Ezetimibe/Simvastatin (Vytorin) significantly altered immunomodulatory gene expression related to inflammation and oxidative stress more than Simvastatin alone. Vytorin also improved lipid profiles and C-reactive protein levels more effectively.
Area of Science:
- Cardiovascular Genetics
- Pharmacogenomics
- Immunomodulation
Background:
- Statins are widely used to manage hypercholesterolemia.
- Pleiotropic effects of statins extend beyond lipid-lowering.
- Combination therapy may offer distinct immunomodulatory benefits.
Purpose of the Study:
- To compare the effects of Ezetimibe/Simvastatin (Vytorin) versus Simvastatin monotherapy on immunomodulatory gene expression.
- To investigate differential gene expression profiles in hypercholesterolemic subjects.
Main Methods:
- Cross-sectional study design.
- Gene expression profiling using Illumina's GenomeStudio.
- Analysis of peripheral blood mononuclear cells from 20 hypercholesterolemic subjects.
Main Results:
- Vytorin modulated genes involved in inflammation, oxidative stress, cellular activation, adhesion, and coagulation.
- Simvastatin primarily affected genes related to cellular apoptosis and proliferation.
- Vytorin demonstrated superior efficacy in improving lipid profiles and reducing C-reactive protein.
Conclusions:
- Ezetimibe/Simvastatin combination therapy induces distinct immunomodulatory gene expression changes compared to Simvastatin monotherapy.
- The observed pleiotropic effects may contribute to the differential clinical efficacies of these treatments.
Keywords:
ACEACSALTARBASTBPCHDCIMTCRPDyslipidemiaEzetimibeHDLILInflammationLDLMicroarrayMononuclear cellsNFk-BPBMCsPlatelet adhesionROSStatinTCTNFTRGThrombosisVWFacute coronary syndromealanine aminotransferaseangiotensin receptor blockersangiotensin-converting enzymeaspartate aminotransferaseblood pressurec-reactive proteincarotid intima-media thicknesscoronary heart diseasehigh-density lipoprotein cholesterolinterleukinlow-density lipoprotein cholesterolnuclear factor kappaBperipheral blood mononuclear cellsreactive oxygen speciestotal cholesteroltriglyceridetumor necrosis factorvon Willebrand factorMore Related Videos
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
01:27Combined Effects of Drugs: Synergism
6.4K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.4K
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
388
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
388
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
230
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
230
01:26Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
01:27Coronary Artery Disease V: Interprofessional Care
450
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450